18
05/10/2012 1 Part 1 v3 What do we know about the effectiveness of drug delivery? Measure tissue concentrations Measure response Derive mathematical relationships is a science which attempts to explain the factors involved in the absorption, distribution and clearance of drug substances in the body: it encompasses the physical and chemical properties of the drug which affects dissolution and the permeability and distributive factors characteristics which affect efficacy.

Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

Embed Size (px)

Citation preview

Page 1: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

1

Part 1 v3

What do we know about the effectiveness of drug delivery?

}  Measure tissue concentrations

}  Measure response }  Derive mathematical

relationships

is a science which attempts to explain the factors involved in the absorption, distribution and clearance of drug substances in the body:

it encompasses the physical and chemical properties of the drug which affects dissolution and the permeability and distributive factors characteristics which affect efficacy.

clivewilson
Text Box
The main elements of this lecture are to link in vitro tests with in vivo tests and we will be considering methods of acquiring clinical data appropriate to making the measurement.
Page 2: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

2

}  A measure of how much drug gets into the systemic circulation and is theoretically available at a site of action

Time (h)

Rel

ease

of dru

g fr

om for

mu

lati

on (m

g)

Pla

sma C

once

ntr

ati

on (u

g/m

l)

Action

Biopharmaceutical Fitness

}  For an oral drug candidate (that is for 80% of all drugs in development) to be developed, the compound must

•  Dissolve •  be absorbed through the gut and •  possess sufficient metabolic stability to generate

adequate drug concentrations at the pharmacologically relevant site so that the desired action is obtained in a reproducible manner

Formulation

}  Formulation-specific behaviour alters the exposure and time course of absorption

•  Matrix tablet versus disintegrating tablet •  Multiparticulate versus nanoparticulate •  Oil versus versus self-emulsifying dispersion

Page 3: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

3

}  Systemic availability represents the amount of drug that is available to the systemic circulation and is usually described in terms of Cmax and AUC.

}  Strictly speaking, it is only the total amount of drug absorbed into the circulation which describes the bioavailable fraction (F).

}  This is measured by the AUC.

AUC Units: µg/ml.h

Plas

ma

Conc

entr

atio

n (µ

g.m

l)

}  Two products are considered to be bioequivalent when their concentration vs time profiles , from the same molar dose, are so similar that they are unlikely to produce clinically relevant differences in therapeutic and/or adverse events.

• Same drug • Different formulations • At the same strength

Page 4: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

4

A matter of adequate therapy

}  The release rate relates to the Cmax and Tmax

Pla

sma C

once

ntr

ati

on

Time (h)

Pla

sma C

once

ntr

ati

on

Time (h)

Pla

sma C

once

ntr

ati

on

Time (h)

} Delivery of constructs ◦  To where they are needed ◦  At the appropriate time ◦  For the appropriate period

Page 5: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

5

}  Originally proposed by Amidon and colleagues (Amidon et al., Pharm. Res. 12: 413-420 , 1995)

}  Proposed that Permeability and Dissolution are the controlling vehicles

}  Adoption by the FDA led to waivers on immediate release products

}  Test in vitro mechanistically rather than in vivo empirically

}  Little mechanistic information can be obtained through a knowledge of AUC or Cmax

}  If two drug products have the same in vitro dissolution profile under all lumenal conditions, they will present the same concentration-time profile at the intestinal surface and this will lead to the same extent of absorption

Page 6: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

6

Objective: In vivo-in vitro correlation

}  ‘Ideal’ vs real life ◦  Lag-phase ◦  Dissolution is faster than

absorption

In v

ivo

abso

rptio

n

In vitro dissolution

100%

100%

Page 7: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

7

}  In vivo in vitro correlation. }  An example of the technique:

Time % d

isso

lved

Pla

sma

Con

c

Time Time % d

isso

lved

80%

Pla

sma

Con

c

Time

T80%

Cmax or Tmax

1 2 3

4 5

}  Solubility Permeability

Class I High Solubility

High Permeability

Class II Low Solubility

High Permeability

Class III High Solubility

Low Permeability

Class IV

Low Solubility Low Permeability

Page 8: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

8

}  Good SOLUBILTY, Good PERMEABILITY }  Paracetamol }  Quinidine }  Metoprolol }  Caffiene }  Most drugs at low doses Comment: IVIVC only if gastric emptying is faster than dissolution

}  Tablet may be completely dissolved but since drug is not absorbed from the stomach. Gastric emptying has to occur to allow intestinal absorption

}  SOLUBILITY is rate-limiting }  Digoxin (some crystal forms) }  Griseofulvin

}  What do you do? ◦  Select a salt form; mill down drug particles

Page 9: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

9

}  Delays gastric emptying

}  Provides more time for dissolution

}  May bind drugs }  May make a better

solvent system - emulsion formation

}  Tamoxifen (dose 20mg) : poorly soluble in water

CAN BE MADE MORE ATTRACTIVE BY SOLVENTS

}  Alphamethyl DOPA (Aminoacid transporter) }  Atenolol (Paracellular transport) }  Verapamil (Candidate for p-glycoprotein efflux

pump) }  Amoxycillin

}  EITHER THERE IS A LIMITED CAPACITY TRANSPORTER ALLOWING THE DRUGS IN

OR:

Page 10: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

10

}  THE BODY RECOGNISES THESE AS POISONS AND TRIES TO THROW THEM OUT OF THE CELL

}  Frusemide }  Hydrochlorthiazide Comment: Brickdust – but some useful

compounds

Page 11: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

11

}  Fewer clinical trials }  Prediction of behaviour by compedial tests }  In vitro/ in vivo correlation (IVIVC)

cgw 601

Four Tablet variants manufactured to capture the extreme ends of the variables. Healthy volunteer study

0 8 16 24 32 40 48 Time (h)

0 8 16 24 32 40 48 Time (h)

0 8 16 24 32 40 48 Time (h)

0 8 16 24 32 40 48 Time (h)

Variant 1 Variant 3

Variant 2 Variant 4

Courtesy Tahseen Mirza 2010, Saudi Pharmaceutical Conference

The problems of an over-discriminatory method..

Courtesy Tahseen Mirza 2010, Saudi Pharmaceutical Conference

0 2 4 6 8 10 12 Time (h)

Page 12: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

12

The 3 Dimensionless Numbers…

MATHS…

ABSORPTION NUMBER

DOSE NUMBER

DISSOLUTION NUMBER

}  Defined as the ratio of the permeability and the intestinal radius multiplied by the residence time (the transit time).

}  An = =tabs

-1tres = tres/tabs

}  Peff/R is the “effective residence time”

}  So lets try and use it…

Peff

R tres

}  Vila Int J Clin Pharmacol Ther Toxicol. 1992 Aug;30(8):280-6.

}  In the small intestine, the absorption rate constants, Ka, at pH 6.2 ranged between 0.38 h-1 for atenolol and 4.28 h-1 for penbutolol. In the colon, the rate of drug absorption at pH 7.5 ranged between 0.12 h-1 for atenolol and 2.15 h-1 for penbutolol.

}  An = tres/tabs = 3/0.38 = 7.9 in the small intestine

}  = 4/0.12 =33 in the colon }  High An Poorly absorbed, Low An well absorbed

Page 13: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

13

Problems……No problems

}  Ratio of the residence time to the dissolution time which itself is ◦  A function of the equilibrium solubility ◦  A function of diffusivity ◦  A function of density ◦  A function of the initial particle radius

}  Simplifies to tres / tdiss }  Ideally 1 or greater }  In the case of solid dosage forms, a combination of

inadequate solubility or diffusivity, or excessive particle size or density can increase the time needed for full dissolution and reduce this ratio

Page 14: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

14

Time (h) Average Drug released (%)

2 <30

4 30-55

8 55-80

12 65-90

}  The dose number is the ratio of the dose to the amount of drug that will dissolve in 250 mL of test solution at the lowest solubility within the pH range 1 to 8.

}  Ideally, this ratio should be below 1 if full dissolution is to be possible in principle. Obviously, higher doses will raise the ratio and make good absorption less likely

Mo / Vo Css

Example: Css= 0.4 mg mL 200 mg dose/250 mL = 0.8 mg mL =0.8/0.4 = 2

}  Case 1 ◦  Dose that is administered= 50 mg ◦  Volume = 250 ml ◦  Css Solubility of drug = 0.2 mg ml-1

�  =0.2/0.2 - DOSE SHOULD DISSOLVE IN ADMINISTERED FLUID

}  Case 2 ◦  Dose = 200 mg ◦  Volume = 100 ml ◦  Solubility of drug = 0.01 mg ml-1

◦  =2/0.01 = 200

Page 15: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

15

}  Weak acids ◦  Mefamic acid 500 litres ◦  Troglitazone 100 litres

}  Neutral compounds ◦  Danazol 200 litres ◦  Atavaquone 1,785 litres ◦  Felodipine 10 litres

Dressman EDAN 28March 04

}  Doesn’t make sense because aqueous solubilities do not reflect what is going on in the gut...

}  Felodipine ◦  Dose 10 mg ◦  Solubility in water 1 µg ml-1 ◦  Solubility in simulated intestinal fluid (fasting) 49 µg ml-1 = 204 ml ◦  Solubility in simulated intestinal fluid (fed) 237 µg

ml-1 = 42 ml }  Food solves the problem easily

Dressman EDAN 28March 04

Page 16: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

16

ORANGE ZONE D:S 250 -1000 ml Simple approaches e.g. micronisation may suffice

GREEN ZONE D:S < 250 ml Confirm with Biorelevant Media

RED ZONE D:S > 1000 ml

Confirm with Biorelevant

Media Simple approaches

e.g. micronisation may suffice

Formulation will require expertise and creativity

Dressman EDAN 28March 04

}  Slow entry }  Efflux and metabolism

Page 17: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

17

“The Grapefruit Juice Story began 10 years ago, during experiments designed to study interactions between a Ca2+ channel antagonist felodipine and alcohol”. “Grapefruit juice was included in the experiments as it masked the taste of the alcohol better than any other fruit juice tested”. “As a result of this, grapefruit juice became a subject to a study itself, as it was discovered to change the effects of felodipine significantly on its own”.

NARINGIN

Gives juice its characteristic taste and colour

Most prevalent Flavonoid found in grapefruit juice

Has no direct effect on human cytochrome P450 enzymes

Its metabolite is a potent inhibitor of the CyP3A4 enzyme - resulting in The Grapefruit Juice Effect

Is hydrolysed to its metabolite NARINGENIN in the small intestine after oral administration

Here are some examples of drugs whose effects are potentiated by the action of Grapefruit Juice.

Ca2+ channel blockers

eg. Felodipine. Antihistamines

eg. Terfenadine.

Immunosuppresant eg. cyclosporin

other drugs include:

• Benzodiazepines • Oral contraceptives • HIV-protease inhibitors

GRAPEFRUIT JUICE POTENTIATES THE

EFFECTS OF...

Page 18: Adv Drug Deliv L1 2012 2013 Part1 v3a (1)

05/10/2012

18

}  Multidrug resistance: MDR

}  Active in the apical cells of the gut

}  Restricts the rate of entry of verapamil and cyclosporine

}  Works in concert with CyP3A4